Skip to content
Roboearth – Lifestyle
Author:
Alphyn Biologics, Inc.
New JDD Research Paper Finds Few Atopic Dermatitis Topicals Treat Full Spectrum of Disease; Alphyn’s Zabalafin Hydrogel Candidate Cited as Potential Multi-Target Option
November 9, 2026